Efficacy and safety of XKH004, a novel dual interleukin-17A/F inhibitory monoclonal antibody, in active ankylosing spondylitis: A 52-week phase 3 randomized study

Molecular Phylogenetics and Evolution · Elsevier

Аннотация

Publication date: October 2026 Source: hLife, Volume 4, Issue 10 Author(s): Ling Zhou, Ran Yan, Songying Ye, Juan Zhao, Xiaofei Shi, Guixiu Shi, Shujie Li, Yanfei Chen, Hui Luo, Yongtao Chen, Rui Wu, Jinying Lin, Zhenyu Jiang, Lingyun Sun, Jiankang Hu, Xiaomei Li, Zhenchun Zhang, Yi Zhao, Jian Xu, Xiaoping Hong

Читать у издателя →

Похожие статьи